As countries move from managing COVID-19 as an acute emergency to integration into longer-term disease control programmes, the ACT-Accelerator partnership is adjusting its ways of working.
In this context, and given that the current Strategic Plan runs until the end of September 2022, work is underway to develop a plan to manage this transition.
This will ensure ACT-A’s ongoing ability to support country needs and demand, while maintaining capacity to manage subsequent waves of COVID-19, if and when new variants emerge.
Will ACT-A’s work continue after September 2022?
Yes, ACT-A’s work to enhance equitable access to COVID-19 countermeasures will continue beyond September 2022.
Although the current ACT-Accelerator Strategic Plan & Budget runs to the end of September 2022, and we do not anticipate publishing a new Strategic Plan, the work of ACT-A will continue beyond that date. For example, the work of ACT-A agencies on the delivery of vaccines and the rollout of test and treat protocols, among other areas of the COVID-19 response, will continue into 2023.
Coordination of implementation among agencies will also continue as needed. We expect to continue updating our ACT-A Commitment Tracker until at least the end of 2022. ACT-A agencies are discussing how and which scopes of work will be maintained, scaled back or kept in a state of readiness in the six month transition period.
What is the ACT-A transition plan and when will it be published?
Work is underway to develop a plan to manage the ACT-Accelerator transition. This plan will ensure ACT-A’s ongoing ability to support country need and demand, while maintaining capacity to manage subsequent waves of COVID-19, if and when new variants emerge. The plan is expected to be published by the end of Q3 2022.
What are the plans for ACT-A fundraising?
ACT-A’s coordinated fundraising campaign, that is led by the ACT-A Facilitation Council’s Financial & Resource Mobilization Working Group, is winding down now that the G7 Summit has concluded. However, ACT-A agencies will continue to fundraise throughout 2022 and beyond as necessary to meet the current funding needs and ensure continuity of support to countries for the roll out and uptake of tools. Plans will remain flexible to accommodate the evolution of the COVID-19 pandemic.
Will there be a permanent ACT-Accelerator?
The WHO white paper ‘10 proposals to build a safer world together - Strengthening the Global Architecture for Health Emergency Preparedness, Response and Resilience’ emphasizes the need to build on the experience and lessons of ACT-A, as well as the Pandemic Influenza Preparedness (PIP) Framework and related initiatives, to establish a fit-for-purpose platform for equitable access to medical countermeasures in future pandemics. The potential composition, operating modalities and enabling capacities for a future countermeasures platform are under discussion in a number of fora.
Will there be a formal review of ACT-A?
Yes, an independent evaluation of ACT-A is being sponsored by the ACT-A Facilitation Council co-chairs Norway and South Africa. The Terms of Reference for the evaluation can be found here. The evaluation will be conducted by an independent Evaluation Service Provider and overseen by a Reference Group comprised of the ACT-A Council co-chairs, six additional countries invited by the co-chairs, and civil society and community representatives. The results of the evaluation are expected to be published in Q4 2022.
Further information can be found on the Evaluation page.
How will the lessons from ACT-A be taken forward in discussions on the future of the global health architecture for pandemic prevention, preparedness and response (PPR)?
The experience, ongoing evaluations and reviews of ACT-A and its Pillars are key inputs for discussions on strengthening the Global Health Architecture for PPR. ACT-A experience and lessons are already being shared in a number of fora, including WHO Member State processes, Board-level discussions of ACT-A partner agencies, and in the ongoing G20 and G7 Presidencies. This is in turn informing discussions on initiatives that range from a new pandemic instrument to a new Financial Intermediary Fund (FIF) for PPR, and a potential finance and health coordination platform for PPR.